This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Mar 1;30(7):759; author reply 759-60.

doi: 10.1200/JCO.2011.39.8057. Epub 2011 Dec 27.

High-dose chemotherapy as adjuvant therapy in breast cancer: could there be a survival benefit?

PMID: 22203770
DOI: 10.1200/JCO.2011.39.8057

Comment

High-dose chemotherapy as adjuvant therapy in breast cancer: could there be a survival benefit?

Mauro Moroni. J Clin Oncol. 2012.

. 2012 Mar 1;30(7):759; author reply 759-60.

doi: 10.1200/JCO.2011.39.8057. Epub 2011 Dec 27.

Author

PMID: 22203770
DOI: 10.1200/JCO.2011.39.8057

No abstract available

PubMed Disclaimer

Comment on

High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.
Berry DA, Ueno NT, Johnson MM, Lei X, Caputo J, Rodenhuis S, Peters WP, Leonard RC, Barlow WE, Tallman MS, Bergh J, Nitz UA, Gianni AM, Basser RL, Zander AR, Coombes RC, Roché H, Tokuda Y, de Vries EG, Hortobagyi GN, Crown JP, Pedrazzoli P, Bregni M, Demirer T. Berry DA, et al. J Clin Oncol. 2011 Aug 20;29(24):3214-23. doi: 10.1200/JCO.2010.32.5910. Epub 2011 Jul 18. J Clin Oncol. 2011. PMID: 21768471 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information